Author

M. Cabrera-Mora

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

D. C. Nguyen· 2 shared F. E.-H. Lee· 2 shared I. Sanz· 2 shared A. Derrico· 1 shared A. Hankus· 1 shared A. Moreno· 1 shared A. Morrison-Porter· 1 shared A. N. Lane· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. C. Nguyen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Majority of human circulating plasmablasts stop blasting: A probable misnomer

D. C. Nguyen, C. Saney, I. T. Hentenaar, M. Cabrera-Mora, M. C. Woodruff, J. Andrews, S. Lonial, I. Sanz, F. E.-H. Lee

The study shows most blood plasmablasts are not actively dividing, suggesting the term 'plasmablast' may be misleading.

bioRxiv · Sep 10, 2023 · PreprintImmunology

Clinical recovery of Macaca fascicularis infected with Plasmodium knowlesi

M. S. Peterson, C. J. Joyner, J. A. Brady, J. S. Wood, M. Cabrera-Mora, C. L. Saney, L. L. Fonseca, W. T. Cheng, J. Jang, S. A. Lapp, S. R. Soderberg, M. V. Nural, J. C. Humphrey, A. Hankus, D. Machiah, , M. R. Galinski

This study tracks clinical and physiological changes in kra monkeys infected with P. knowlesi, revealing mechanisms of resilience to malaria.

bioRxiv · Jun 28, 2021Pathology

Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection

N. S. Haddad, D. C. Nguyen, M. E. Kuruvilla, A. Morrison-Porter, F. Anam, K. S. Cashman, R. P. Ramonell, S. Kyu, A. S. Saini, M. Cabrera-Mora, A. Derrico, D. Alter, J. D. Roback, M. Horwath, J. B. O'Keefe, , F. E.-H. Lee

This paper develops a multiplex immunoassay to measure SARS-CoV-2 antibody responses and finds that severe COVID-19 is associated with higher early antibody levels against S1 and N proteins.

bioRxiv · Dec 4, 2020 · PreprintImmunology